McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Alula Creates DTC Marketplace for Cancer Patients

by McKesson Ventures | Apr 30, 2021 | Media Coverage

Alula, McKesson’s first digital cancer treatment marketplace partner, opened up its DTC marketplace in April. The purpose? Make it easier for cancer patients to find and purchase the products they need at any given stage of their treatment. Liya Shuster-Bier was a...

Michelle Snyder Brings a Creative Spirit to Marketing and Investing

by McKesson Ventures | Apr 27, 2021 | Media Coverage

Michelle Snyder is McKesson Ventures’ newest partner, having joined the firm in late 2020. But Snyder is a digital health veteran and she’s seen innovation in the industry from every angle, from marketing to mentoring to investing. In a recent StartUp Health Fireside...

Covid-19 serves as catalyst for effort to diversity clinical trial enrollment

by McKesson Ventures | Apr 23, 2021 | Media Coverage

McKesson Ventures Vice President and Partner Carrie Williams was a speaker on a panel at MedCity’s INVEST conference, April 22, 2021. She and the other panelists, Allison Kalloo, founder and president of Clinical Ambassador; Doug Langa, executive vice president of...

McKesson Ventures highlights investment priorities amidst a trail of successful exits

by McKesson Ventures | Apr 20, 2021 | Media Coverage

In a recent interview, McKesson Ventures Partner Michelle Snyder discussed the latest trends in digital health and how McKesson Ventures chooses its investments. As a corporate venture group, the McKesson Ventures team is well positioned to identify emerging trends in...
Real-World Evidence Should Be Part of Clinical Trials in Oncology

Real-World Evidence Should Be Part of Clinical Trials in Oncology

by McKesson Ventures | Apr 6, 2020 | Media Coverage

McKesson’s Sarah Alwardt, Ph.D, recently wrote in OncLive about the importance of real-world evidence (RWE) in the field of cancer treatment research. Fewer than 5 percent of adults with cancer enroll in clinical trials, but sufficient enrollment is necessary in order...
McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star

McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star

by McKesson Ventures | Jan 29, 2020 | Media Coverage

McKesson Ventures Principal Carrie Hurwitz Williams has been honored as one of 10 Global Corporate Venturing Rising Stars. Williams joined McKesson Ventures in 2017, bringing with her more than 15 years of experience in health care from several vantage points within...
Page 3 of 9«12345...»Last »

Recent Posts

  • McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing
  • Oath Surgical Raises $24M to Build the First Surgeon-Owned, AI-Powered Surgical System
  • Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
  • Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation
  • Komodo Health Introduces Marmot, the AI Built to Accelerate Healthcare Innovation
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth

Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

©2025 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow